ABEGRIN, created in 2005 (United States), from 584 sister brands and 17477 competing brands. ABEGRIN is owned by ASTRAZENECA, listed on the stock exchange of London Its International Securities Identification Number (ISIN) is GB0009895292. ABEGRIN is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
ASTRAZENECA
(ABEGRIN)
over 5 years*
GBX 24,948.16